$NMTC News
Last published 1w ago
- 1w agoNMTCNeuroOne® Announces Peer-Reviewed Publication of Initial Clinical Experience with OneRF® Trigeminal Nerve Ablation SystemGlobeNewswireStudy Reports Immediate Pain Freedom in 14 of 15 Patients; all Patients Achieved Favorable Pain Outcomes at a Mean Six-Month Follow-Up Multi-Contact Probe Technology Enabled Mapping and Treatment of Trigeminal Nerve
- 2w agoNMTCNeuroOne Featured in New York Post on OneRF® Patient’s Remarkable Journey to Overcome Debilitating Facial PainGlobeNewswireNeuroOne’s FDA 510(k)-Cleared OneRF Trigeminal Nerve Ablation System Offers Hope for Patients Suffering from Trigeminal Neuralgia EDEN PRAIRIE, Minn., Oct. 27, 2026 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies
- 2w agoNMTCNeuroOne Secures First Pharmaceutical Industry Purchase Order for StereoCED™ Drug Delivery Platform to Support Tier 1 Global Pharmaceutical Company's Research ProgramGlobeNewswireMajor Commercial Milestone Represents Important Step Toward Potential Long-Term Collaborations with Global Pharmaceutical Companies EDEN PRAIRIE, Minn., Oct. 22, 2026 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies
- 1mo agoNMTCNeuroOne® Joins Dartmouth-Led Research Team on $1 Million NIH Grant to Advance Neurotransmitter Sensing TechnologyGlobeNewswireNew NIH Award will Initially Provide NeuroOne Approximately $200,000 through April 2027 EDEN PRAIRIE, Minn., Oct. 08, 2026 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC)
- 1mo agoNMTCNeuroOne® Expands U.S. Commercialization of FDA-Cleared OneRF® Trigeminal Nerve Ablation System with New Southern California Distribution AgreementGlobeNewswireEDEN PRAIRIE, Minn., Sept. 17, 2026 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on transforming the
- 1y agoNMTCNeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025GlobeNewswireEDEN PRAIRIE, Minn., Sept. 08, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical
- 1y agoNMTCNeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial PainGlobeNewswireFDA Clearance Further Validates Technology Platform and Offers Alternatives to Pharmaceutical and Invasive Surgical Treatments EDEN PRAIRIE, Minn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies
- 1y agoNMTCNeuroOne Medical Technologies Corporation (NMTC) Q3 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoNMTCNeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9%GlobeNewswireCompleted Oversubscribed $8.2 Million Capital Raise; Funded Through At Least Fiscal Year 2026 EDEN PRAIRIE, Minn., Aug. 14, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne"
- 1y agoNMTCNeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - UpdateGlobeNewswireEDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical
- 1y agoNMTCNeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern TimeGlobeNewswireEDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical
- 1y agoNMTCNeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark OfficeGlobeNewswirePatent Strengthens Intellectual Property Portfolio Surrounding Neural Probe Technologies EDEN PRAIRIE, Minn., July 23, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC)
- 1y agoNMTCNeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate SecretaryGlobeNewswireEDEN PRAIRIE, Minn., June 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical
- 1y agoNMTCNeuroOne to Attend MedInvest's MedTech, AI & Digital Health Conference on June 3-4, 2025GlobeNewswireEDEN PRAIRIE, Minn., May 29, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical
- 1y agoNMTCNeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%GlobeNewswireFiled 510(k)Submission with FDA for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain Ahead of Schedule Company Fully Funded Through at Least Fiscal Year 2026 Following Oversubscribed $8.2 Million
- 1y agoNMTCNeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical AdvisorGlobeNewswireSignificant Neurological Expertise to Help Drive Clinical Development Strategy and Growth with New Technologies EDEN PRAIRIE, Minn., May 12, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation
- 1y agoNMTCNeuroOne® to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern TimeGlobeNewswireEDEN PRAIRIE, Minn., May 01, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical
- 1y agoNMTCNeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial PainGlobeNewswireMulti-Contact Probe Provides Alternative to Pharmaceutical and Invasive Surgical Treatments Submission Completed Earlier Than Anticipated EDEN PRAIRIE, Minn., April 23, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical
- 1y agoNMTCNeuroOne® Issues Letter to ShareholdersGlobeNewswireCompany Now Fully Funded Through at least Fiscal 2026; Company Confirms No Material Impact from Global Tariffs EDEN PRAIRIE, Minn., April 16, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation
- 1y agoNMTCNeuroOne® OneRF® Technology Success Story Featured on Fox NewsGlobeNewswirePediatric Patient Treated with OneRF® Ablation System Goes From Up to 10 Nightly Seizures to Zero EDEN PRAIRIE, Minn., April 14, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC)
- 1y agoNMTCNeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common StockGlobeNewswireEDEN PRAIRIE, Minn., April 04, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) (the "Company"), a medical technology company focused on improving surgical care options and outcomes for
- 1y agoNMTCNeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common StockGlobeNewswireEDEN PRAIRIE, Minn., April 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) (the "Company"), a medical technology company focused on improving surgical care options and outcomes for
- 1y agoNMTCNeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace - UpdateGlobeNewswireEDEN PRAIRIE, Minn., March 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical
- 1y agoNMTCNeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's MarketplaceGlobeNewswireEDEN PRAIRIE, Minn., March 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical
- 1y agoNMTCNeuroOne CEO Joins Today's Marketplace To Discuss The Latest Treatments for EpilepsyGlobeNewswireNEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- Today's Marketplace (TMP) is proud to announce a featured interview with NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) CEO Dave Rosa and Jessica Clark, DNP,
- 1y agoNMTCNeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial PainGlobeNewswireSubmission for New Intended Use That Leverages Company's Patented OneRF® Technology Platform Expected in May 2025 EDEN PRAIRIE, Minn., March 11, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation
- 1y agoNMTCNeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services ConferenceGlobeNewswireEDEN PRAIRIE, Minn., March 05, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical
- 1y agoNMTCNeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate UpdateGlobeNewswireTotal revenue of $6.3M Includes $3.3 Million of Product Revenue in Addition to a One-Time Upfront Payment of $3.0 Million in License Revenue from Zimmer Biomet EDEN PRAIRIE, Minn., Feb. 12, 2025 (GLOBE NEWSWIRE) --
- 1y agoNMTCNeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern TimeGlobeNewswireEDEN PRAIRIE, Minn., Feb. 05, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical
- 1y agoNMTCNeuroOne® Regains Compliance with Nasdaq Listing RequirementsGlobeNewswireEDEN PRAIRIE, Minn., Feb. 04, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical
- 1y agoNMTCNeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 MillionGlobeNewswireFirst Quarter Fiscal 2025 Revenue Includes a One-Time Upfront Payment of $3.0 Million in Collaboration Revenue from Zimmer Biomet and $3.2M in Product Revenue Management to Host Virtual Investor Webinar Today at 11:00
- 1y agoNMTCNeuroOne® Announces Change of Virtual Investor Webinar to Friday, January 10, 2024GlobeNewswireCompany to Provide Overview of Business Model and Expected Revenue Acceleration in Fiscal Year 2025 EDEN PRAIRIE, Minn., Jan. 06, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC)
- 1y agoNMTCNeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. ESTGlobeNewswireCompany to Provide Overview of Business Model and Expected Revenue Acceleration in Fiscal Year 2025 EDEN PRAIRIE, Minn., Jan. 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC)
- 1y agoNMTCNeuroOne Medical Technologies Corporation (NMTC) Q4 2024 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoNMTCNeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025GlobeNewswireCompany's Exclusive Distribution Agreement with Zimmer Biomet included $3.0 Million Upfront Payment: Expected to Drive Revenue and Expand Margins Significantly EDEN PRAIRIE, Minn., Dec. 17, 2024 (GLOBE NEWSWIRE) --
- 1y agoNMTCNeuroOne® to Report Fourth Quarter and Fiscal Year 2024 Financial Results on December 17 at 9:00 a.m. Eastern TimeGlobeNewswireEDEN PRAIRIE, Minn., Dec. 04, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical
- 1y agoNMTCNeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap EventACCESS NewswireEDEN PRAIRIE, MN / ACCESSWIRE / November 13, 2024 / NeuroOne Medical Technologies Corporation , a medical technology company focused on improving surgical
- 2y agoNMTCNeuroOne® Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF™ Ablation SystemGlobeNewswireLicense Provides Exclusive Commercialization Rights for US Distribution and Certain OUS MarketsAgreement expected to boost NeuroOne sales revenue and profitability EDEN PRAIRIE, Minn., Oct. 31, 2024 (GLOBE NEWSWIRE)
- 2y agoNMTCNeuroOne® Medical Technologies to Present at the 2024 ThinkEquity ConferenceGlobeNewswireEDEN PRAIRIE, Minn., Oct. 24, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and
- 2y agoNMTCNeuroOne® Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain ConferenceGlobeNewswireMinimally invasive technology would allow for percutaneous placement of a paddle electrode Renowned pain specialist Dr. Sean Li to present on this innovative tool for lower back pain EDEN PRAIRIE, Minn., Sept. 24,
- 2y agoNMTCNeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in ClevelandGlobeNewswireForty-four ablations performed successfully in one patient Patient currently reportedly seizure free with improvements in mood and memory EDEN PRAIRIE, Minn., Sept. 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical
- 2y agoNMTCNeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceGlobeNewswireEDEN PRAIRIE, Minn., Sept. 05, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and
- 2y agoNMTCNeuroOne Medical Technologies Corporation (NMTC) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoNMTCNeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate UpdateGlobeNewswireEDEN PRAIRIE, Minn., Aug. 14, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and
- 2y agoNMTCNeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14GlobeNewswireEDEN PRAIRIE, Minn., Aug. 12, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical
- 2y agoNMTCNeuroOne® Announces $2.65 Million Equity Financing And $3.0 Million Credit FacilityGlobeNewswireProceeds to be used for OneRF commercialization activities and to bridge the Company to the close of a potential distribution arrangement with a strategic partner currently in the diligence process EDEN PRAIRIE, Minn.,
- 2y agoNMTCNeuroOne® Announces First in Human Ablations Completed with OneRF™ Ablation SystemGlobeNewswireFive ablations performed successfully in one patient Procedure performed at patient's bedside saving time and cost associated with the operating room EDEN PRAIRIE, Minn., June 25, 2024 (GLOBE NEWSWIRE) -- NeuroOne
- 2y agoNMTCNeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF AblationGlobeNewswireICD-10-PCS code for first to market, FDA-cleared thin-film, sEEG-guided RF ablation system effective October 1, 2024 Specific procedure code positions OneRF™ Ablation System for broader adoption and awareness
- 2y agoNMTCNeuroOne Medical Technologies Corporation (NMTC) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoNMTCNeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate UpdateGlobeNewswireEDEN PRAIRIE, Minn., May 14, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and